Detalimogene has received Fast Track designation from the U.S. Food and Drug Administration (FDA) based on its potential to address the high unmet medical need for patients with BCG-unresponsive CIS … [+10315 chars]...
Read moreNew York, USA, July 03, 2025 (GLOBE NEWSWIRE) -- Complicated Urinary Tract Infections Market Set to Experience Stunning Growth During the Forecast Period (20252034) | DelveInsight The growth of the… [+27175 chars]...
Read more